Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-93.81%
Change (1 year)
Categories
Operating Margin for Mallinckrodt Pharmaceuticals (MNK)
Operating Margin as of May 2024 (TTM): -76.35%
According to Mallinckrodt Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -76.35%. At the end of 2021 the company had an Operating Margin of -37.57%.
Operating Margin history for Mallinckrodt Pharmaceuticals from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -37.57% | -13.45% |
| 2020 | -43.41% | -13.74% |
| 2019 | -50.32% | -60.06% |
| 2018 | -126.01% | -6690.2% |
| 2017 | 1.91% | -72.3% |
| 2016 | 6.90% | 7.32% |
| 2015 | 6.43% | -144.97% |
| 2014 | -14.30% | -349.49% |
| 2013 | 5.73% | -50.06% |
| 2012 | 11.48% | -4.54% |
| 2011 | 12.03% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -129.97% | 🇺🇸 USA |
 General Electric GE | -1.37% | -98.21% | 🇺🇸 USA |
 Zogenix ZGNX | -259.55% | 239.95% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -20.53% | -73.11% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.